Bupivacaine Hydrochloride

盐酸布比卡因

Report date: 2026/05/20 20:02:01

Base Information

Drug NameBupivacaine Hydrochloride
Drug Alias NameBupivacainum Hydrochloride布比卡因盐酸盐盐酸布哌卡因bupivacaineBupivacain +[22] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockers
TargetsSodium channel alpha subunit
Therapy Area/IndicationsVasomotor symptomStress Disorders, Post-TraumaticAnterior Cruciate Ligament Injuries +[47] 
Global Approved IndicationsAnesthesia
Approved Indications in ChinaAnesthesia
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[22] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHospira
China Registration ClassN/A

Develop Information

Active CompaniesInnocollTian Medical IncThe Royal'S Institute Of Mental Health Research +[24] 
Inactive CompaniesUtah State UniversityGrace Therapeutics IncDurect +[37] 
Active IndicationsStress Disorders, Post-TraumaticOpioid-Related DisordersHeadache +[20] 
Inactive IndicationsVasomotor symptomAnterior Cruciate Ligament InjuriesTibial Fractures +[27] 

Other Information

ATC CodeN01BB01
Related LinksWikipediaDrugBankKEGG